Farmacología, Farmacognosia y Botánica
Departamento
Hospital Universitario 12 de Octubre
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (27)
2023
-
Finerenone protects against progression of kidney and cardiovascular damage in a model of type 1 diabetes through modulation of proinflammatory and osteogenic factors
Biomedicine and Pharmacotherapy, Vol. 168
-
Imbalance in Bone Morphogenic Proteins 2 and 7 Is Associated with Renal and Cardiovascular Damage in Chronic Kidney Disease
International Journal of Molecular Sciences, Vol. 24, Núm. 1
2022
-
Intervention by a clinical pharmacist carried out at discharge of elderly patients admitted to the internal medicine department: influence on readmissions and costs
BMC Health Services Research, Vol. 22, Núm. 1
-
Specialized Proresolving Mediators Protect Against Experimental Autoimmune Myocarditis by Modulating Ca2+ Handling and NRF2 Activation
JACC: Basic to Translational Science, Vol. 7, Núm. 6, pp. 544-560
2020
-
Beneficial effects of paricalcitol on cardiac dysfunction and remodelling in a model of established heart failure
British Journal of Pharmacology, Vol. 177, Núm. 14, pp. 3273-3290
-
Finerenone Reduces Intrinsic Arterial Stiffness in Munich Wistar Frömter Rats, a Genetic Model of Chronic Kidney Disease
American Journal of Nephrology, Vol. 51, Núm. 4, pp. 294-303
2018
-
Deficiency of NOD1 improves the β-adrenergic modulation of Ca2+ handling in a mouse model of heart failure
Frontiers in Physiology, Vol. 9, Núm. JUN
-
Finerenone attenuates endothelial dysfunction and albuminuria in a chronic kidney disease model by a reduction in oxidative stress
Frontiers in Pharmacology, Vol. 9, Núm. OCT
2017
-
Drug syrups: Errors in drug labels with possible consequences in patients with heritary fructose intolerance
Anales de Pediatria, Vol. 87, Núm. 6, pp. 351-353
-
Identification of new SNPs associated with severe toxicity to capecitabine
Pharmacological Research, Vol. 120, pp. 133-137
-
Mild and short-term caloric restriction prevents obesity-induced cardiomyopathy in young zucker rats without changing in metabolites and fatty acids cardiac profile
Frontiers in Physiology, Vol. 8, Núm. FEB
-
Rapid, automated, and specific immunoassay to directly measure matrix metalloproteinase-9-tissue inhibitor of metalloproteinase-1 interactions in human plasma using AlphaLISA technology: A new alternative to classical ELISA
Frontiers in Immunology, Vol. 8, Núm. JUL
-
Role of NOD1 in Heart Failure Progression via Regulation of Ca2+ Handling
Journal of the American College of Cardiology, Vol. 69, Núm. 4, pp. 423-433
-
Use of exome sequencing to determine the full profile of genetic variants in the fluoropyrimidine pathway in colorectal cancer patients affected by severe toxicity
Pharmacogenomics, Vol. 18, Núm. 13, pp. 1215-1223
2016
-
Global cardiovascular protection in chronic kidney disease
Nature Reviews Cardiology, Vol. 13, Núm. 10, pp. 603-608
-
Role of matrix metalloproteinase-9 in chronic kidney disease: A new biomarker of resistant albuminuria
Clinical Science, Vol. 130, Núm. 7, pp. 525-538
2015
-
Fetal undernutrition is associated with perinatal sex-dependent alterations in oxidative status
Journal of Nutritional Biochemistry, Vol. 26, Núm. 12, pp. 1650-1659
-
Genetic predisposition to albuminuria is associated with increased arterial stiffness: Role of elastin
British Journal of Pharmacology, Vol. 172, Núm. 17, pp. 4406-4418
-
High-fat diet induces endothelial dysfunction through a down-regulation of the endothelial AMPK-PI3K-Akt-eNOS pathway
Molecular Nutrition and Food Research, Vol. 59, Núm. 3, pp. 520-532
-
NOD1, a new player in cardiac function and calcium handling
Cardiovascular Research, Vol. 106, Núm. 3, pp. 375-386